Ala. Court Nixes $78M Price Inflation Verdict Against Sandoz

Law360, New York (July 13, 2012, 6:26 PM ET) -- The Alabama Supreme Court on Friday overturned a $78.4 million jury verdict against generic-drug maker Sandoz Inc. for charging the state's Medicaid program artificially inflated drug prices, marking the second time the state's high court has dismantled a jury award against a drug company.

Citing its decision in a similar case involving AstraZeneca LP, Alabama's high court said the state's fraud claims fail because it hadn't relied on Sandoz's allegedly false information.

“Alabama law requires that a party claiming to be the victim of fraud must...
To view the full article, register now.